Assessment of Antioxidant Enzyme Superoxide Dismutase (SOD) in Oral Cancer: Systematic Review and Meta‐Analysis

K Mohideen, K Chandrasekaran, S Dhungel… - Disease …, 2024 - Wiley Online Library
Objective. The present article aims to comprehensively review the existing literature on
superoxide dismutase (SOD) levels, an antioxidant enzyme, in oral cancer. Method. An …

[HTML][HTML] The roles of protein ubiquitination in tumorigenesis and targeted drug discovery in lung cancer

Z Ye, J Yang, H Jiang, X Zhan - Frontiers in Endocrinology, 2023 - frontiersin.org
The malignant lung cancer has a high morbidity rate and very poor 5-year survival rate.
About 80%-90% of protein degradation in human cells is occurred through the ubiquitination …

[HTML][HTML] Drivers Underlying Metastasis and Relapse in Medulloblastoma and Targeting Strategies

KO Holmberg, A Borgenvik, M Zhao, G Giraud… - Cancers, 2024 - mdpi.com
Simple Summary In this review, we summarize reported molecular mechanisms underlying
tumor progression and relapse of medulloblastoma, one of the most frequent malignant …

An overview of the therapeutic strategies for neoplastic meningitis due to breast cancer: when and why?

M Bardhan, D Dey, V Suresh, B Javed… - Expert Review of …, 2024 - Taylor & Francis
Introduction Neoplastic meningitis (NM), also known as leptomeningeal carcinomatosis, is
characterized by the infiltration of tumor cells into the meninges, and poses a significant …

[HTML][HTML] Intrathecal Trastuzumab for HER2-Positive Cancer of Unknown Primary Leptomeningeal Metastasis: A Case Report

K Oka, S Futamura, T Harada - Cureus, 2024 - ncbi.nlm.nih.gov
Cancer of unknown primary (CUP) and leptomeningeal metastasis are difficult conditions
with limited treatment options. We report a case of CUP leptomeningeal metastasis that was …

[HTML][HTML] Therapeutic strategies for HER2-positive breast cancer with central nervous system involvement: a literature review and future perspectives

MI Passalacqua, G Ciappina, M Di Pietro… - Translational Cancer …, 2023 - ncbi.nlm.nih.gov
Therapeutic strategies for HER2-positive breast cancer with central nervous system
involvement: a literature review and future perspectives - PMC Back to Top Skip to main content …

Identifying the Preoperative Radiological Risk Features in Patients with Leptomeningeal Carcinomatosis Undergoing Cerebrospinal Fluid Drainage

Q Hou, Y Mo, J Guo, T Deng, L Mo, C Wei - World Neurosurgery, 2024 - Elsevier
Background Patients with leptomeningeal carcinomatosis (LMC) experience a poor
prognosis and rapid progression, and cerebrospinal fluid drainage (CSFD) is used to …

Personalized therapy guided by longitudinal liquid biopsies for treatment of leptomeningeal disease from lung adenocarcinoma: A case report

M Lai, T Mu, M Liu, Q Hu, J Li, T Huang… - Oncology …, 2024 - spandidos-publications.com
Molecular-based targeted therapies have significantly benefited certain patients with cancer;
however, those with leptomeningeal disease (LMD) persistently exhibit a poor prognosis …

[HTML][HTML] Freiburg Neuropathology Case Conference: A 54-Years-Old Patient with Fatigue, Headaches, and Personality Changes

M Frosch, AJ Braun, J Grauvogel, M Prinz… - Clinical …, 2024 - Springer
A 54-year-old male patient presented with symptoms of fatigue, headaches and changes in
personality. The neurological status on admission to hospital was unremarkable. Computed …

Comparative evaluation of the diagnostic and prognostic performance of CNSide™ versus standard cytology for leptomeningeal disease

HR Appel, M Rubens, M Roy, R Kotecha… - Neuro-Oncology …, 2024 - academic.oup.com
Background This retrospective study compares real-world performance of cerebrospinal
fluid (CSF) CNSide™ versus cytology in leptomeningeal disease (LMD). Methods …